Article Information
History
- August 14, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Yonghyun Nam1,
- Jae-Seung Yun1,2,
- Seung Mi Lee1,3,
- Ji Won Park1,4,
- Ziqi Chen5,
- Brian Lee1,
- Anurag Verma6,
- Xia Ning5,7,8,
- Li Shen1,9 and
- Dokyoon Kim1,9,*
- 1Department of Biostatistics, Epidemiology and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
- 2Division of Endocrinology and Metabolism, Department of Internal Medicine, St. Vincent’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea
- 3Department of Obstetrics and Gynecology, Seoul National University College of Medicine, Seoul, South Korea
- 4Department of Surgery, Seoul National University College of Medicine, Seoul, South Korea
- 5Computer Science and Engineering Department, College of Engineering, The Ohio State University, Columbus, USA
- 6Department of Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
- 7Biomedical Informatics Department, College of Medicine, The Ohio State University, Columbus, USA
- 8Translational Data Analytics Institute, The Ohio State University, Columbus, USA
- 9Institute for Biomedical Informatics, University of Pennsylvania, Philadelphia, USA
- ↵* corresponding author dokyoon.kim{at}pennmedicine.upenn.edu
Posted August 14, 2020.
Network reinforcement driven drug repurposing for COVID-19 by exploiting disease-gene-drug associations
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos